Skip to content
Menu
Network
Sub-Menu
Browse by Subject
Browse by Publisher
Join the Network
Get Started
Subscribe
Support
Contact
Search
Close
Enter Search Terms
Search
Molly Grammel
ID:
1b83b168-2619-30fb-68c4
/
Unclaimed
/
Organization:
Goodwin Procter
Published Works
7 articles
Federal Circuit Denies Injunction Pending Appeal After Amgen Beat Preliminary Injunction for Biosimilar Aflibercept
Big Molecule Watch ·
October 23, 2024
cite
Celltrion Launches 80 mg YUFLYMA (adalimumab-aaty) in the U.S.
Big Molecule Watch ·
January 26, 2024
cite
Regeneron Sues Celltrion For Proposed Biosimilar of Eylea in West Virginia District Court
Big Molecule Watch ·
November 14, 2023
cite
Formycon and Celltrion Announce FDA Submission of aBLAs Seeking Approval to Market Aflibercept Biosimilars
Big Molecule Watch ·
June 30, 2023
cite
Regeneron Files Expedited Motion Challenging Mylan’s Designation of Entire aBLA Production as Outside Counsel’s Eyes Only
Big Molecule Watch ·
December 12, 2022
cite
Previous
1
2
Next
